Stevens-Johnson syndrome associated with intravenous acetazolamide administration for evaluation of cerebrovascular reactivity

Neurologia Medico-Chirurgica

Volumn 46, Issue 3, 2006, Pages 161-163

  Ogasawara, Kuniaki ^a   Tomitsuka, Nobuhiko ^a   Kobayashi, Masakazu ^a   Komoribayashi, Nobukazu ^a   Fukuda, Takeshi ^a   Saitoh, Hideo ^a   Inoue, Takashi ^a   Ogawa, Akira ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Acetazolamide; Cerebrovascular reactivity; Stevens Johnson syndrome

Indexed keywords

ACETAZOLAMIDE; ACETYLSALICYLIC ACID; IOFETAMINE I 123; PERINDOPRIL; PREDNISOLONE;

ADULT; ANAMNESIS; ARTICLE; BLOOD VESSEL REACTIVITY; BRAIN BLOOD VESSEL; CASE REPORT; DRUG DOSE REDUCTION; ERYTHEMA; HUMAN; HYPERTENSION; LYMPHOCYTE TRANSFORMATION TEST; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NUCLEAR MAGNETIC RESONANCE IMAGING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STEVENS JOHNSON SYNDROME; TRANSIENT ISCHEMIC ATTACK; ULCER;

ACETAZOLAMIDE; CARBONIC ANHYDRASE INHIBITORS; CEREBROVASCULAR CIRCULATION; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; STEVENS-JOHNSON SYNDROME;

EID: 33645299804     PISSN: 04708105     EISSN: 13498029     Source Type: Journal    
DOI: 10.2176/nmc.46.161     Document Type: Article

References (12)

1. Carrol OM, Bryan PA, Robinson RJ: Stevens-Johnson syndrome associated with long-acting sulfonamides. JAMA 195: 691-693, 1966
2. Cotter JB: Methazolamide-induced Stevens-Johnson syndrome: a warning! Arch Ophthalmol 116: 117, 1998
3. Derick RJ: Carbonic anhydrase inhibitors, in Mauger TF, Craig EL (eds): Hevener's Ocular Pharmacology, ed 6. St Louis, Mo, CV Mosby, 1994, pp 45-50
4. Flach AJ, Smith RE, Fraunfelder FT: Stevens-Johnson syndrome associated with methazolamide treatment reported in two Japanese-American women. Ophthalmology 102: 1677-1680, 1995
5. Hosoda K, Kawaguchi T, Shibata Y, Kamei M, Kidoguchi K, Koyama J, Fujita S, Tamaki N: Cerebral vasoreactivity and internal carotid artery flow help to identify patients at risk for hyperperfusion after carotid endarterectomy. Stroke 32: 1567-1573, 2001
6. Huff JC, Weston WL, Tonnesen MG: Erythema multiforme: a critical review of characteristics, diagnostic criteria, and causes. J Am Acad Dermatol 8: 763-775, 1983
7. Kuroda S, Houkin K, Kamiyama H, Mitsumori K, Iwasaki Y, Abe H: Long-term prognosis of medically treated patients with internal carotid or middle cerebral artery occlusion: can acetazolamide test predict it? Stroke 32: 2110-2116, 2001
8. Ogasawara K, Ogawa A, Yoshimoto T: Cerebrovascular reactivity to acetazolamide and outcome in patients with symptomatic internal carotid or middle cerebral artery occlusion: a xenon-133 single-photon emission computed tomography study. Stroke 33: 1857-1862, 2002
9. Ogasawara K, Yukawa H, Kobayashi M, Mikami C, Konno H, Terasaki K, Inoue T, Ogawa A: Prediction and monitoring of cerebral hyperperfusion after carotid endarterectomy by using single-photon emission computerized tomography scanning. J Neurosurg 99: 504-510, 2003
10. Shirato S, Kagaya F, Suzuki Y, Joukou S: Stevens-Johnson syndrome induced by methazolamide treatment. Arch Ophthalmol 115: 550-553, 1997
11. Sud RN, Grewal SS: Stevens Johnson syndrome due to Diamox. Indian J Ophthalmol 29: 101-103, 1981
12. Yonas H, Smith HA, Durham SR, Pentheny SL, Johnson DW: Increased stroke risk predicted by compromised cerebral blood flow reactivity. J Neurosurg 79: 483-489, 1993